New York State Common Retirement Fund Increases Stake in Concentrix Corporation $CNXC

New York State Common Retirement Fund increased its position in shares of Concentrix Corporation (NASDAQ:CNXC) by 327.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 78,106 shares of the company’s stock after buying an additional 59,823 shares during the period. New York State Common Retirement Fund owned about 0.13% of Concentrix worth $3,605,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in CNXC. Hussman Strategic Advisors Inc. acquired a new stake in Concentrix during the third quarter worth approximately $1,938,000. Envestnet Asset Management Inc. boosted its holdings in shares of Concentrix by 32.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 220,030 shares of the company’s stock valued at $11,630,000 after buying an additional 54,449 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in shares of Concentrix in the 3rd quarter valued at $9,627,000. Brandywine Global Investment Management LLC acquired a new stake in Concentrix during the 2nd quarter worth $5,942,000. Finally, Natixis purchased a new stake in Concentrix in the second quarter valued at $1,872,000. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Stock Performance

Shares of CNXC opened at $39.93 on Friday. The stock has a market capitalization of $2.46 billion, a P/E ratio of -1.92, a P/E/G ratio of 0.42 and a beta of 0.50. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.40 and a current ratio of 1.40. Concentrix Corporation has a 1 year low of $31.63 and a 1 year high of $66.00. The company’s fifty day moving average is $40.37 and its two-hundred day moving average is $44.62.

Concentrix (NASDAQ:CNXC) last issued its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. The business had revenue of $2.55 billion for the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.26 earnings per share. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. On average, sell-side analysts predict that Concentrix Corporation will post 10.11 earnings per share for the current year.

Concentrix Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, February 10th. Investors of record on Friday, January 30th will be paid a $0.36 dividend. The ex-dividend date is Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 3.6%. Concentrix’s payout ratio is -6.91%.

Insiders Place Their Bets

In other Concentrix news, CEO Christopher A. Caldwell acquired 1,000 shares of the business’s stock in a transaction on Thursday, January 29th. The stock was purchased at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares of the company’s stock, valued at $13,422,120.25. The trade was a 0.28% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

CNXC has been the topic of a number of research analyst reports. Robert W. Baird set a $52.00 target price on Concentrix in a research report on Wednesday, January 14th. Weiss Ratings lowered Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Barrington Research reissued an “outperform” rating and issued a $62.00 price objective on shares of Concentrix in a report on Monday, January 12th. Finally, Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, January 17th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $63.75.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.